526 related articles for article (PubMed ID: 18308296)
1. Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.
Nehru B; Verma R; Khanna P; Sharma SK
Brain Res; 2008 Mar; 1201():122-7. PubMed ID: 18308296
[TBL] [Abstract][Full Text] [Related]
2. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
Verma R; Nehru B
Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
[TBL] [Abstract][Full Text] [Related]
3. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
[TBL] [Abstract][Full Text] [Related]
4. The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA.
Alam M; Mayerhofer A; Schmidt WJ
Behav Brain Res; 2004 May; 151(1-2):117-24. PubMed ID: 15084427
[TBL] [Abstract][Full Text] [Related]
5. L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats.
Alam M; Schmidt WJ
Behav Brain Res; 2004 Aug; 153(2):439-46. PubMed ID: 15265640
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
Inden M; Kitamura Y; Tamaki A; Yanagida T; Shibaike T; Yamamoto A; Takata K; Yasui H; Taira T; Ariga H; Taniguchi T
Neurochem Int; 2009 Dec; 55(8):760-7. PubMed ID: 19647776
[TBL] [Abstract][Full Text] [Related]
7. Ameliorative effect of Sida cordifolia in rotenone induced oxidative stress model of Parkinson's disease.
Khurana N; Gajbhiye A
Neurotoxicology; 2013 Dec; 39():57-64. PubMed ID: 23994302
[TBL] [Abstract][Full Text] [Related]
8. Systematic administration of iptakalim, an ATP-sensitive potassium channel opener, prevents rotenone-induced motor and neurochemical alterations in rats.
Yang Y; Liu X; Long Y; Wang F; Ding JH; Liu SY; Sun YH; Yao HH; Wang H; Wu J; Hu G
J Neurosci Res; 2005 May; 80(3):442-9. PubMed ID: 15795934
[TBL] [Abstract][Full Text] [Related]
9. Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone.
Fleming SM; Zhu C; Fernagut PO; Mehta A; DiCarlo CD; Seaman RL; Chesselet MF
Exp Neurol; 2004 Jun; 187(2):418-29. PubMed ID: 15144868
[TBL] [Abstract][Full Text] [Related]
10. Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats.
Alam M; Danysz W; Schmidt WJ; Dekundy A
Toxicol Appl Pharmacol; 2009 Oct; 240(2):198-207. PubMed ID: 19616571
[TBL] [Abstract][Full Text] [Related]
11. Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson's disease in rats.
Karuppagounder SS; Madathil SK; Pandey M; Haobam R; Rajamma U; Mohanakumar KP
Neuroscience; 2013 Apr; 236():136-48. PubMed ID: 23357119
[TBL] [Abstract][Full Text] [Related]
12. D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease.
Imamura K; Takeshima T; Kashiwaya Y; Nakaso K; Nakashima K
J Neurosci Res; 2006 Nov; 84(6):1376-84. PubMed ID: 16917840
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson's disease.
Thakur P; Nehru B
Neuroscience; 2013 Feb; 231():420-31. PubMed ID: 23159314
[TBL] [Abstract][Full Text] [Related]
14. Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity.
Kumar P; Padi SS; Naidu PS; Kumar A
Methods Find Exp Clin Pharmacol; 2007; 29(1):19-25. PubMed ID: 17344940
[TBL] [Abstract][Full Text] [Related]
15. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.
Testa CM; Sherer TB; Greenamyre JT
Brain Res Mol Brain Res; 2005 Mar; 134(1):109-18. PubMed ID: 15790535
[TBL] [Abstract][Full Text] [Related]
16. Further evidence of centrophenoxine mediated protection in aluminium exposed rats by biochemical and light microscopy analysis.
Nehru B; Bhalla P; Garg A
Food Chem Toxicol; 2007 Dec; 45(12):2499-505. PubMed ID: 17688990
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of a novel model of Parkinson's disease by intra-striatal infusion of the pesticide rotenone.
Mulcahy P; Walsh S; Paucard A; Rea K; Dowd E
Neuroscience; 2011 May; 181():234-42. PubMed ID: 21277943
[TBL] [Abstract][Full Text] [Related]
18. Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain.
Bashkatova V; Alam M; Vanin A; Schmidt WJ
Exp Neurol; 2004 Apr; 186(2):235-41. PubMed ID: 15026259
[TBL] [Abstract][Full Text] [Related]
19. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.
Takeuchi H; Yanagida T; Inden M; Takata K; Kitamura Y; Yamakawa K; Sawada H; Izumi Y; Yamamoto N; Kihara T; Uemura K; Inoue H; Taniguchi T; Akaike A; Takahashi R; Shimohama S
J Neurosci Res; 2009 Feb; 87(2):576-85. PubMed ID: 18803299
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D₁ and D₂ receptor subtypes functional regulation in cerebral cortex of unilateral rotenone lesioned Parkinson's rat model: Effect of serotonin, dopamine and norepinephrine.
Paul J; Kuruvilla KP; Mathew J; Kumar P; Paulose CS
Parkinsonism Relat Disord; 2011 May; 17(4):255-9. PubMed ID: 21306935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
